Letter: comparative efficacy of biological therapy in patients with ulcerative colitis

被引：4
|
作者：
Singh, S. [1 ]
Garg, S. K. [2 ]
Wang, Z. [3 ]
Murad, M. H. [3 ]
Loftus, E. V., Jr. [1 ]
机构：
[1] Mayo Clin, Div Gastroenterol & Hepatol, Dept Internal Med, Rochester, MN 55905 USA
[2] Univ Minnesota, Dept Surg, Minneapolis, MN 55455 USA
[3] Mayo Clin, Robert D & Patricia E Kern Ctr Sci Hlth Care Deli, Rochester, MN USA
来源：
ALIMENTARY PHARMACOLOGY & THERAPEUTICS | 2014年 / 39卷 / 12期
关键词：
NETWORK METAANALYSIS;
D O I：
10.1111/apt.12760
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：1432 / 1433
页数：2
相关论文
共 50 条
  • [21] Infliximab versus Adalimumab: Can We Choose the Right One for the Right Patients with Ulcerative Colitis?
    Park, Sang Hyoung
    Ye, Byong Duk
    Yang, Suk-Kyun
    GUT AND LIVER, 2022, 16 (01) : 138 - 140
  • [22] Efficacy and safety of biologic agents and tofacitinib in moderate-to-severe ulcerative colitis: A systematic overview of meta-analyses
    Pantavou, Katerina
    Yiallourou, Anneza, I
    Piovani, Daniele
    Evripidou, Despo
    Danese, Silvio
    Peyrin-Biroulet, Laurent
    Bonovas, Stefanos
    Nikolopoulos, Georgios K.
    UNITED EUROPEAN GASTROENTEROLOGY JOURNAL, 2019, 7 (10) : 1285 - 1303
  • [23] Efficacy and Safety of Adalimumab in Pediatric Ulcerative Colitis: A Real-life Experience from the SIGENP-IBD Registry
    Aloi, Marina
    Bramuzzo, Matteo
    Arrigo, Serena
    Romano, Claudio
    D'Arcangelo, Giulia
    Lacorte, Doriana
    Gatti, Simona
    Illiceto, Maria T.
    Zucconi, Francesca
    Dilillo, Dario
    Zuin, Giovanna
    Knafelz, Daniela
    Ravelli, Alberto
    Cucchiara, Salvatore
    Alvisi, Patrizia
    JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2018, 66 (06) : 920 - 925
  • [24] Efficacy and Safety of Infliximab Versus Adalimumab in Adult Subjects With Moderate to Severe Ulcerative Colitis: A Systematic Review and Meta-Analysis
    Salman, Ahmed
    Salman, Mohamed A.
    Elewa, Ahmed
    Awwad, Asmaa M.
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (06)
  • [25] Efficacy and safety of mirikizumab compared with currently approved biologic drugs for the treatment of ulcerative colitis: A systematic review and network meta-analysis
    Mocko, Pawel
    Koperny, Magdalena
    Sladowska, Katarzyna
    Holko, Przemyslaw
    Kowalska-Bobko, Iwona
    Kawalec, Pawel
    PHARMACOTHERAPY, 2024, 44 (10): : 811 - 821
  • [26] Comparative onset of effect of biologics and small molecules in moderate-to-severe ulcerative colitis: a systematic review and network meta-analysis
    Attauabi, Mohamed
    Dahl, Emilie Kristine
    Burisch, Johan
    Gubatan, John
    Nielsen, Ole Haagen
    Seidelin, Jakob Benedict
    ECLINICALMEDICINE, 2023, 57
  • [27] Comparative efficacy and safety of Chinese medicine injections as an adjunctive therapy for cervical cancer in Chinese patients: a network meta-analysis
    Ma, Fei
    Wang, Qun
    Zhang, Di
    Wang, Zihong
    Xie, Hui
    Liu, Xianghong
    Zhang, Hongxing
    Song, Haiyan
    Sun, Shiguang
    PHARMACEUTICAL BIOLOGY, 2024, 62 (01) : 170 - 182
  • [28] Comparative Efficacy and Safety of Biological Agents in the Treatment of Lupus Nephritis: A Network Meta-Analysis
    Lee, Young Ho
    Song, Gwan Gyu
    PHARMACOLOGY, 2023, 108 (01) : 17 - 26
  • [29] Comparison of Long-term Outcomes of Infliximab versus Adalimumab Treatment in Biologic-Naive Patients with Ulcerative Colitis
    Lee, Yong Il
    Park, Yehyun
    Park, Soo Jung
    Kim, Tae Il
    Kim, Won Ho
    Cheon, Jae Hee
    GUT AND LIVER, 2021, 15 (02) : 232 - 242
  • [30] Efficacy of ustekinumab vs. advanced therapies for the treatment of moderately to severely active ulcerative colitis: a systematic review and network meta-analysis
    Welty, Margaux
    Mesana, Laura
    Padhiar, Amie
    Naessens, Dominik
    Diels, Joris
    van Sanden, Suzy
    Pacou, Maud
    CURRENT MEDICAL RESEARCH AND OPINION, 2020, 36 (04) : 595 - 606
12345